Asthma: Best treatment options

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Learning Objectives: To understand the principles of asthma management in patients of different ages, and to outline major avoidance measures, classes of medications available, and indications for immunotherapy (IT). Data Sources: MEDLINE and major textbooks of allergy and immunology. Conclusions: There has been an understanding of asthma as a chronic inflammatory disease for many decades but recent information about mediators and cytokines has led to new therapies and better understanding of the effects of IT and other preventive measures. The best treatment for any individual patient depends upon many factors and is a decision to be made between the patient and the physician. It seems that the best response to IT occurs in those who are highly sensitive to unavoidable allergens, and who experienced a late-phase asthmatic response to the allergen initially. New data suggest that IT should be considered early, as it may prevent progression of asthma to more severe, less reversible disease. The best therapy results in the ablation of airway early- and late-phase reactivity.

Original languageEnglish (US)
Pages (from-to)9-12
Number of pages4
JournalAnnals of Allergy, Asthma and Immunology
Volume87
Issue number1 SUPPL.
DOIs
StatePublished - Jan 1 2001

Fingerprint

Immunotherapy
Asthma
Allergens
Textbooks
Information Storage and Retrieval
Therapeutics
Allergy and Immunology
MEDLINE
Chronic Disease
Learning
Cytokines
Physicians

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Asthma : Best treatment options. / Wray, Betty Beasley.

In: Annals of Allergy, Asthma and Immunology, Vol. 87, No. 1 SUPPL., 01.01.2001, p. 9-12.

Research output: Contribution to journalArticle

@article{220ff1c0874b4cc7b978a9557c1cc201,
title = "Asthma: Best treatment options",
abstract = "Learning Objectives: To understand the principles of asthma management in patients of different ages, and to outline major avoidance measures, classes of medications available, and indications for immunotherapy (IT). Data Sources: MEDLINE and major textbooks of allergy and immunology. Conclusions: There has been an understanding of asthma as a chronic inflammatory disease for many decades but recent information about mediators and cytokines has led to new therapies and better understanding of the effects of IT and other preventive measures. The best treatment for any individual patient depends upon many factors and is a decision to be made between the patient and the physician. It seems that the best response to IT occurs in those who are highly sensitive to unavoidable allergens, and who experienced a late-phase asthmatic response to the allergen initially. New data suggest that IT should be considered early, as it may prevent progression of asthma to more severe, less reversible disease. The best therapy results in the ablation of airway early- and late-phase reactivity.",
author = "Wray, {Betty Beasley}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S1081-1206(10)62189-8",
language = "English (US)",
volume = "87",
pages = "9--12",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Asthma

T2 - Best treatment options

AU - Wray, Betty Beasley

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Learning Objectives: To understand the principles of asthma management in patients of different ages, and to outline major avoidance measures, classes of medications available, and indications for immunotherapy (IT). Data Sources: MEDLINE and major textbooks of allergy and immunology. Conclusions: There has been an understanding of asthma as a chronic inflammatory disease for many decades but recent information about mediators and cytokines has led to new therapies and better understanding of the effects of IT and other preventive measures. The best treatment for any individual patient depends upon many factors and is a decision to be made between the patient and the physician. It seems that the best response to IT occurs in those who are highly sensitive to unavoidable allergens, and who experienced a late-phase asthmatic response to the allergen initially. New data suggest that IT should be considered early, as it may prevent progression of asthma to more severe, less reversible disease. The best therapy results in the ablation of airway early- and late-phase reactivity.

AB - Learning Objectives: To understand the principles of asthma management in patients of different ages, and to outline major avoidance measures, classes of medications available, and indications for immunotherapy (IT). Data Sources: MEDLINE and major textbooks of allergy and immunology. Conclusions: There has been an understanding of asthma as a chronic inflammatory disease for many decades but recent information about mediators and cytokines has led to new therapies and better understanding of the effects of IT and other preventive measures. The best treatment for any individual patient depends upon many factors and is a decision to be made between the patient and the physician. It seems that the best response to IT occurs in those who are highly sensitive to unavoidable allergens, and who experienced a late-phase asthmatic response to the allergen initially. New data suggest that IT should be considered early, as it may prevent progression of asthma to more severe, less reversible disease. The best therapy results in the ablation of airway early- and late-phase reactivity.

UR - http://www.scopus.com/inward/record.url?scp=0034945602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034945602&partnerID=8YFLogxK

U2 - 10.1016/S1081-1206(10)62189-8

DO - 10.1016/S1081-1206(10)62189-8

M3 - Article

C2 - 11476480

AN - SCOPUS:0034945602

VL - 87

SP - 9

EP - 12

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 1 SUPPL.

ER -